This article provides evidence-based information to help patients and healthcare professionals navigate this complex topic, emphasising the importance of open communication with prescribers about all substance use
Actor Jesse Plemons recently lost weight but denies using medication
In April 2025, AstraZeneca Plc could receive European Medicines Agency (EMA) approval for ECC5004, its oral GLP-1RA, for the treatment of obesity, intensifying competition in the oral treatment segment
Addressing these and other vital clinical questions will require additional investment in basic, translational, clinical and implementation research. They conclude: The management of hyperglycaemia in type 2 diabetes has become extraordinarily complex with the number of glucose-lowering medications now available
We provide ongoing guidance to ensure you're seeing results safely and effectively
doi: 10.3389/fimmu.2021.696074 38 KhanIUllahNZhaLBaiYKhanAZhaoTet al